Skip to search formSkip to main contentSkip to account menu

Talsaclidine

Known as: (3R)-3-(2-Propynyloxy)quinuclidine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET
The norepinephrine transporter (NET) transports norepinephrine from the synapse into presynaptic neurons, where norepinephrine… 
Highly Cited
2009
Highly Cited
2009
Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonists.
Review
2007
Review
2007
M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer’s disease
M1 muscarinic receptors (M1 mAChRs) play a role in an apparent linkage of three major hallmarks of Alzheimer’s disease (AD… 
Highly Cited
2004
Highly Cited
2004
Beta‐secretase BACE1 is differentially controlled through muscarinic acetylcholine receptor signaling
The β‐amyloid peptides derived by proteolytic cleavage from the amyloid precursor protein (APP) play a major role in the… 
Highly Cited
2003
Highly Cited
2003
Treatment with the selective muscarinic ml agonist talsaclidine decreases cerebrospinal fluid levels of Aβ42 in patients with Alzheimer's disease
The amyloid p-peptides Aβ40 and Aβ42 are highly amyloidogenic constituents of brain Pamyloid plaques in Alzheimer's disease (AD… 
2002
2002
Memory-related task performance by aged rhesus monkeys administered the muscarinic M1-preferring agonist, talsaclidine
HeadingAbstractRationale. Muscarinic-acetylcholine receptor agonists are yet to be used clinically for the treatment of Alzheimer… 
2002
2002
Talsaclidine (WAL 2014 FU), a muscarinic M1 receptor agonist for the treatment of Alzheimer's disease
Since the discovery of muscarinic receptor subtypes, extensive research has been going on attempting to provide treatments for… 
Highly Cited
2000
Highly Cited
2000
Treatment with the Selective Muscarinic Agonist Talsaclidine Decreases Cerebrospinal Fluid Levels of Total Amyloid β‐Peptide in Patients with Alzheimer's Disease
Abstract: Brain amyloid load in Alzheimer's disease (AD) is, at least in genetic forms, associated with overproduction of amyloid… 
Highly Cited
1999
Highly Cited
1999
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
The purpose of our studies was to determine the effects of muscarinic receptor agonists on conditioned avoidance responding in… 
Highly Cited
1997
Highly Cited
1997
Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License